š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
RATIONALE: Drugs used in chemotherapy work in different ways to stop cancer...
Status
Completed
Location
Aurora Presbyterian Hospital
Start Date
1993-05-07
Trial ID
NCT00002514
Treatments Being Tested
This study is open-label, multi-center, prospective study, which targets ch...
Status
Recruiting
Location
Kyungpook National University Chilgok Hospital
Start Date
2024-04-04
Trial ID
NCT05827549
Treatments Being Tested
This study evaluates the value of bortezomib in combination with specified ...
Status
Completed
Location
Stanford University, School of Medicine
Start Date
2013-03
Trial ID
NCT01769209
Extranodal natural killer (NK)/T-cell lymphoma (ENKTL), nasal type, is a di...
Status
Unknown
Location
Ruijin Hospital
Start Date
2016-03-16
Trial ID
NCT02631239
Treatments Being Tested
Background: \- The best treatment for ovarian and related female reproduct...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2010-01
Trial ID
NCT01313078
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of DDGP re...
Status
Unknown
Location
Oncology Department of The First Affiliated Hospital of Zhengzhou University
Start Date
2011-01
Trial ID
NCT01501149
The study evaluates the efficacy and tolerability of a risk- and subtype-ad...
Status
Completed
Location
University Hospital, Medical Dept. II
Start Date
1993-04
Trial ID
NCT00199069
This multicentric phase III study is designed to assess the efficacy and sa...
Status
Completed
Location
Erasmus MC
Start Date
2008-10
Trial ID
NCT00784017
Treatments Being Tested
Erwinaze will be administered intravenously at a dose of 25,000 IU/m2 (dose...
Status
Completed
Location
University of Maryland Greenebaum Cancer Center
Start Date
2014-04
Trial ID
NCT02283190
Treatments Being Tested
This is a phase 1/2 study of a drug called Ixazomib in combination with cyt...
Status
Active Not Recruiting
Location
Children's Hospital Los Angeles
Start Date
2019-02-12
Trial ID
NCT03817320